-
-
-
-
-
-
-
MacroGenics Announces Achievement of $10 Million Milestone Related to Retifanlimab Collaboration with Incyte
-
-
-
-
-
-
-
MacroGenics Announces Lancet Oncology Publication of Margetuximab Data in Gastric Cancer
-
-
-
-
-
-
-
MacroGenics Provides Update on FDA Review of Margetuximab for HER2-Positive Metastatic Breast Cancer
-
-
-
-
-
-
-
MacroGenics Outlines Corporate Priorities for 2020
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

